Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBIT Margin: 2023-2024

Historic EBIT Margin for Artiva Biotherapeutics (ARTV) over the last 1 years, with Mar 2024 value amounting to -5,773.71%.

  • Artiva Biotherapeutics' EBIT Margin was N/A to -5,773.71% in Q1 2024 from the same period last year, while for Mar 2024 it was -110.22%, marking a year-over-year change of. This contributed to the annual value of -26,805.58% for FY2024, which is 2671400.00% down from last year.
  • Artiva Biotherapeutics' EBIT Margin amounted to -5,773.71% in Q1 2024, which was down 1,033.52% from -509.36% recorded in Q4 2023.
  • Artiva Biotherapeutics' 5-year EBIT Margin high stood at 40.56% for Q3 2023, and its period low was -5,773.71% during Q1 2024.
  • For the 2-year period, Artiva Biotherapeutics' EBIT Margin averaged around -2,007.27%, with its median value being -1,147.96% (2023).